Dr. Sigei is a medical doctor with over 10 years work experience in clinical medicine, clinical research and pharmaceutical and in-vitro diagnostics medical affairs. Since June 2019, he is serving as the Medical Affairs Manager for Anglophone Africa at BioMérieux, a French in vitro diagnostic company, where he is responsible for leading the scientific and medical engagement of BioMérieux clinical diagnostic portfolio in English speaking countries of East, West and Southern Africa. After working as a doctor in clinical practice and clinical research, Dr. Sigei began his career in medical affairs by joining Novartis Pharmaceutical Services in 2013 as Medical Science Liaison for East Africa where I took on the role of scientifically engaging regional stakeholders, gathering medical insights in key therapeutic areas and supporting product strategy by carrying out key educational and capacity building activities. He was later promoted to the position of Medical Advisor, a more strategic role leading medical affairs strategy and later to Head of Medical Affairs for East Africa & Head of Medical Operations for Sub-Sahara Africa a senior leadership position with overall responsibility for Medical Affairs strategy and operations, Medical talent development, building medical capabilities and driving pre-launch strategy. In this time he was recognized with various accolades including the Business Daily Kenya Top 40 Men Under 40 2017. Dr. Sigei holds a Bachelor of Medicine & Bachelor of Surgery Degree from University of Nairobi as well as Master of Science in Public Health (London) and 2 Post-graduate Diplomas in Tropical Medicine & Hygiene (EADTMH - London) and Global Health - Non-Communicable Diseases (Edinburgh). His passion is in collaborating to provide solutions to health technology utilization and access with focus on clinical research, medical education, scientific engagement, patient access and mentoring.

Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.